Skip to main content
. Author manuscript; available in PMC: 2022 Mar 2.
Published in final edited form as: J Inherit Metab Dis. 2013 Jul 27;37(2):255–261. doi: 10.1007/s10545-013-9642-y

Fig. 2.

Fig. 2

EndoPAT study results of control (a) and MPS-II (b) Control (a) shows normal endothelial vasodilator function (Reactive Hyperemia Index, RHI: 2.05) characterized by an increase in the signal amplitude after cuff release relative to baseline. MPS II patient (b) shows endothelial vasodilator dysfunction without an increase in signal amplitude after cuff release (RHI: 0.62)